Gerrica Davidson, NP
Adult Health · Little Rock, ARNPI 1811691371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 27.9% of the total. That places this record below the midpoint for adult health clinicians in AR, where the typical reported total is $670.
Across 5 payments — averaging $26.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$37
- SK Life Science, Inc.$28
- Teva Pharmaceuticals USA, Inc.$26
- Neurocrine Biosciences, Inc.$23
- Otsuka America Pharmaceutical, Inc.$18
What the payments were for
- Food & beverage$132100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 1 | $37 |
| SK Life Science, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
How this compares
$132 in reported general payments places this provider in the 25th percentile of 154 adult health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $3,729 |
| Vancomycin HclVancomycin/Water For Inj (Peg) | 36 | $3,169 |
| Divalproex Sodium | 34 | $2,868 |
| XareltoRivaroxaban | 11 | $2,719 |
| Sodium Chloride0.9 % Sodium Chloride | 37 | $2,705 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 19 | $2,392 |
| Pregabalin | 59 | $1,815 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $1,783 |
| LantusInsulin Glargine,hum.Rec.Anlog | 18 | $1,311 |
| AdmelogInsulin Lispro | 11 | $1,179 |
| Tramadol Hcl | 108 | $1,174 |
| Lorazepam | 97 | $1,116 |
| CeftriaxoneCeftriaxone Sodium | 47 | $1,088 |
| Potassium Chloride | 35 | $985 |
| Duloxetine Hcl | 14 | $842 |
Paid to pharmacies, not to this prescriber.
Other adult health in Little Rock
- Holly MooreLittle Rock$59K
- Stephanie RogersLittle Rock$4K
- Lara SandersLittle Rock$2K
- Traci MotesLittle Rock$2K
- Kimberly AtwellLittle Rock$1K
- Amanda BullLittle Rock$1K
- Deborah ShipmanJonesboro$41K
- Lisa HurdJonesboro$12K
- Kari SchrankFayetteville$9K
- Amanda McClureFayetteville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.